Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Gastroenterology. 2017 Nov 2;154(3):556–567.e18. doi: 10.1053/j.gastro.2017.10.036

Figure 3.

Figure 3

Efficient frontiers with efficient screening strategies for non-transplant cystic fibrosis and transplant cystic fibrosis patients. Total costs and life-years gained from screening were discounted (3% discounting rate) and 100% adherence was assumed for screening, diagnostic and surveillance test. Optimal screening strategies are labelled and indicated by arrows.